Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias
Open Access
- 1 January 1973
- journal article
- clinical trial
- Published by Oxford University Press (OUP)
- Vol. 49 (567) , 18-23
- https://doi.org/10.1136/pgmj.49.567.18
Abstract
Summary: Ro 3-3528, a non-selective β-adrenoceptor blocking drug which lacks intrinsic activity, produces a dose-response effect in hyperthyroid tachycardia, and shows no dysrhythmic properties. In hyperthyroid patients, β-blocking drugs of this nature are preferable to those possessing intrinsic sympathomimetic activity, which may have dysrhythmic properties in this condition.Keywords
This publication has 14 references indexed in Scilit:
- Ro 3-3528, a ?-adrenoceptor blocking agent: Oral and intravenous pharmacokinetic studies in normal volunteersEuropean Journal of Clinical Pharmacology, 1973
- Pharmacology of 4‐hydroxypropranolol, a metabolite of propranololBritish Journal of Pharmacology, 1971
- Comparison of propranolol and LB 46 (prinodolol) on hyperthyroid tachycardiaPostgraduate Medical Journal, 1971
- Plasma Propranolol Levels in the Quantitative Assessment of -adrenergic Blockade in ManBMJ, 1970
- Comparison of the effects of propranolol and MJ 1999 on cardiac β‐adrenoceptors in manBritish Journal of Pharmacology, 1970
- Plasma propranolol levels in adults With observations in four childrenClinical Pharmacology & Therapeutics, 1970
- COMPARISON OF SOME PROPERTIES OF PRONETHALOL AND PROPRANOLOLBritish Journal of Pharmacology and Chemotherapy, 1965
- Catecholamine Depletion in ThyrotoxicosisCirculation, 1965
- Pharmacodynamic Effects of Beta-Adrenergic Receptor Blockade in Patients with Hyperthyroidism *Journal of Clinical Investigation, 1964
- Effects of Oral and Intramuscular Administration of Reserpine in ThyrotoxicosisNew England Journal of Medicine, 1957